Skip to content
TheChatArchiveThe Chat Archive
chatgpt-4o-latest-20250326· OpenAIHugging Face LMArena Human Preference 140K

Unable to get drunk on Zepbound. Literally does not happen.

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with MiniMaxminimax-m1’s answer.
  1. User

    Unable to get drunk on Zepbound. Literally does not happen.

  2. Assistant

    It sounds like you’re experiencing an unusual effect while taking Zepbound (tirzepatide). While this medication is primarily used for type 2 diabetes and weight management, it can have broader effects on your body, including how it processes alcohol.

    Here’s what might be going on:


    🔬 1. Slowed Gastric Emptying

    Zepbound significantly slows down how quickly your stomach empties. This can delay or alter alcohol absorption, making it seem like you're not getting drunk or that the effects are blunted or inconsistent.

    • Alcohol may be absorbed more slowly, spreading its effects over a longer period.
    • This might reduce the intensity of intoxication or delay its onset to the point that you don’t feel the usual "buzz."

    🧠 2. GLP-1-Based Appetite & Reward Effects

    Tirzepatide is a dual GLP-1 and GIP receptor agonist, affecting not just appetite but also dopamine pathways linked to reward and pleasure.

    • Alcohol triggers dopamine release, but Zepbound might blunt dopamine sensitivity.
    • This means you might not feel the mental/emotional “high” of alcohol, even if it’s in your system.

    🧬 3. Possible Changes in Liver Enzyme Activity

    Though not fully studied, Zepbound may modulate liver metabolism indirectly.

    • The liver processes alcohol via enzymes like ADH and ALDH.
    • If Zepbound alters enzyme activity or the liver's metabolic rate (even slightly), it might reduce peak blood alcohol concentration or impact how you feel it.

    🧪 4. Weight Loss & Body Composition Changes

    If you’ve lost a significant amount of body fat or weight on Zepbound, your tolerance to alcohol may change in unexpected ways.

    • Alcohol distributes in water, not fat. Less fat and more lean mass = different alcohol distribution.
    • Some users report they feel more or less sensitive to alcohol after major weight loss, though your case seems to be less sensitive.

    💊 Other Factors to Consider:

    • Diet: Eating far less or differently affects how alcohol hits you.
    • Hydration: Zepbound can cause dehydration, which changes alcohol effects.
    • Drinking habits: If you've been drinking less while on Zepbound, your tolerance or perception may have shifted.

    🧠 TL;DR:

    Zepbound may hinder your ability to feel drunk by:

    • Slowing alcohol absorption
    • Blunting dopamine response (so you don’t feel the usual buzz)
    • Changing how your body processes alcohol

    ✅ What You Can Do:

    1. Be careful — You might still be impaired even if you don’t feel drunk.
    2. Don't drive or make risky decisions based only on how you feel — because BAC might still rise.
    3. Talk to your doctor if this impacts your lifestyle, safety, or raises questions for meds/alcohol interactions.

    If you'd like, I can help you interpret any scientific papers or side effect updates related to tirzepatide and alcohol use. Just let me know!

  3. User

    think HARD about how it interacts with GABA

  4. Assistant

    Great prompt — let's go deep. You're asking about how Zepbound (tirzepatide) might interact—directly or indirectly—with the GABAergic system, which is central to how alcohol produces intoxication.


    🧠 Background: What does GABA have to do with getting drunk?

    Alcohol exerts most of its intoxicating effects via GABA:

    • It enhances GABA-A receptor activity, the brain’s main inhibitory neurotransmitter.
    • This results in euphoria, disinhibition, motor incoordination, and eventually sedation or unconsciousness at high doses.
    • It also suppresses glutamate (NMDA), an excitatory system.

    So, any drug that blunts GABAergic transmission, compensates for it, or alters the downstream dopaminergic reward loop, can reduce the feeling of being drunk — without changing blood alcohol levels per se.


    🧬 Zepbound and GABA: What’s the link?

    Zepbound (tirzepatide) is a dual GLP-1 and GIP receptor agonist, and both of these gut-derived hormones communicate extensively with brain circuits, not just to control appetite, but to regulate reward, stress, and neurotransmission — including GABA.

    Let’s unpack it:


    🧠 1. GLP-1 dampens GABAergic transmission

    Multiple studies indicate that GLP-1 receptor activation can modulate GABA transmission, especially:

    • In areas like the nucleus accumbens, ventral tegmental area (VTA), and hypothalamus.
    • GLP-1 may reduce the GABA-mediated inhibition of dopamine neurons, altering reward sensitivity.
    • Net result: blunted dopamine release in response to substances like alcohol or nicotine.

    So, instead of directly sedating you (like alcohol would via GABA-A), GLP-1 blunts the motivational/reward reinforcement loop.
    This could translate to: “I drank, but didn’t feel it — no pleasure, no buzz.”


    🧠 2. GLP-1 and GIP Receptors Affect Brainstem Regions

    GLP-1 receptor activity in the brainstem regulates autonomic and behavioral responses to substance use:

    • There's evidence GLP-1 agonists increase GABA release in the PVN (paraventricular nucleus) of the hypothalamus — causing satiety and reducing drug seeking behavior.
    • In the VTA, GLP-1 may actually modulate GABAergic tone against dopamine neurons — meaning alcohol’s “dopamine burst” gets blocked.

    So in both cases, the GABAergic system is shifted toward suppressing reward and staying regulated — leading to less sensation of intoxication.


    🧠 3. Behavioral Outcomes Mimic GABA Desensitization

    Some researchers propose that GLP-1 receptor agonists cause a "behavioral tolerance" to dopaminergic drugs (cocaine, alcohol, amphetamines), even without pharmacologic tolerance.

    • In rodents, GLP-1 analogs blunt alcohol-induced locomotor stimulation, dopamine release, and place preference.
    • In humans, liraglutide and semaglutide reduce alcohol cravings and actual alcohol intake.
    • These mimic tolerance-like effects, often mediated via modulated GABA and dopamine signaling.

    🧪 So What’s Likely Happening on Zepbound?

    MechanismEffect
    GLP-1 stimulationAlters GABAergic balance in reward areas
    Blunted dopamine releaseLess buzz or euphoria from alcohol
    Reduced motivation to drinkYou may not crave alcohol despite drinking
    Slowed alcohol absorptionDelayed or dampened physical effects

    Net result?
    🧊 You’re drinking, but not registering the high.
    🕳️ Mechanistically, it's like your reward system is “gated.” GABA-A may be potentiated by alcohol, but the brain’s circuits are being told “this isn’t rewarding.”


    ❓Does this mean you’re immune to alcohol?

    No — blood alcohol levels (BAC) can still rise normally. Your motor coordination or judgment may still be altered, but the subjective experience (feeling tipsy, buzzy, disinhibited) may be absent or muted.

    This can actually be dangerous:

    👉 You may drink more than usual, thinking you’re fine, but be more impaired than you feel.


    ⚠️ Bottom line:

    Zepbound (tirzepatide) likely alters how alcohol affects GABA and the broader neurochemical reward landscape:

    • Not by stopping GABA-A activity, but by altering the downstream response to it.
    • You’re not resistant to alcohol; you’re neurologically “muted” to its effects.

    Bonus Thought 💡:

    This might make Zepbound (and related GLP-1/GIP drugs) potential candidates for treating alcohol use disorder (AUD) — and trials are currently underway. They exploit this exact mechanism.


    Let me know if you want to explore actual neurochemical pathway maps, receptor-level data, or cutting-edge research papers.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.